The largest subgroup were patients with classic PMD (n = 10) followed by patients with congenital PMD (n = 5), three patients each with transitional, intermediate PMD, and SPG2, two patients with PLP0-mutations and two female patients (Suppl.Table2). This evidence concerns the gene PLP1 and Pelizeaus-Merzbacher spectrum disorder.